These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine. de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345 [TBL] [Abstract][Full Text] [Related]
24. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission. Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330 [TBL] [Abstract][Full Text] [Related]
25. Limbic leukotomy for intractable major affective disorders: a 7-year follow-up study using nine comprehensive psychiatric test evaluations. Cho DY; Lee WY; Chen CC J Clin Neurosci; 2008 Feb; 15(2):138-42. PubMed ID: 18068369 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders. Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120 [TBL] [Abstract][Full Text] [Related]
27. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia]. Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343 [TBL] [Abstract][Full Text] [Related]
28. Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up. Alptekin K; Erkoç S; Göğüş AK; Kültür S; Mete L; Uçok A; Yazici KM Psychiatry Res; 2005 Jun; 135(2):103-11. PubMed ID: 15923043 [TBL] [Abstract][Full Text] [Related]
29. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study]. Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453 [TBL] [Abstract][Full Text] [Related]
30. One-year functional outcomes of naturalistically treated patients with schizophrenia. Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065 [TBL] [Abstract][Full Text] [Related]
32. Symptom dimensions and needs of care among patients with schizophrenia in hospital and the community. Nakanishi M; Setoya Y; Kodaka M; Makino H; Nishimura A; Yamauchi K; Mimura M; Sato H; Arata H; Yukumi H; Amagasa T; Ueno H; Miyamoto Y; Sugie T; Anzai N Psychiatry Clin Neurosci; 2007 Oct; 61(5):495-501. PubMed ID: 17875027 [TBL] [Abstract][Full Text] [Related]
33. Combined bilateral anterior cingulotomy and ventral capsule/ventral striatum deep brain stimulation for refractory obsessive-compulsive disorder with major depression: do combined procedures have a long-term benefit? Chang WS; Roh D; Kim CH; Chang JW Restor Neurol Neurosci; 2013; 31(6):723-32. PubMed ID: 23979095 [TBL] [Abstract][Full Text] [Related]
34. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial. Tang WK; Ungvari GS Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772 [TBL] [Abstract][Full Text] [Related]
36. Long-term treatment with long-acting risperidone in Korean patients with schizophrenia. Lee MS; Ko YH; Lee SH; Seo YJ; Kim SH; Joe SH; Han CS; Lee JH; Jung IK Hum Psychopharmacol; 2006 Aug; 21(6):399-407. PubMed ID: 16915580 [TBL] [Abstract][Full Text] [Related]
37. Bilateral anterior capsulotomy and amygdalotomy for mental retardation with psychiatric symptoms and aggression: A case report. Zhang S; Zhou P; Jiang S; Li P; Wang W Medicine (Baltimore); 2017 Jan; 96(1):e5840. PubMed ID: 28072743 [TBL] [Abstract][Full Text] [Related]
38. Familiality in a five-factor model of schizophrenia psychopathology: findings from a 16-month follow-up study. Ritsner M; Ratner Y; Gibel A; Weizman R Psychiatry Res; 2005 Sep; 136(2-3):173-9. PubMed ID: 16098602 [TBL] [Abstract][Full Text] [Related]
39. Stereotactic amygdalotomy in the management of severe aggressive behavioral disorders. Mpakopoulou M; Gatos H; Brotis A; Paterakis KN; Fountas KN Neurosurg Focus; 2008; 25(1):E6. PubMed ID: 18590383 [TBL] [Abstract][Full Text] [Related]
40. [What impedes discharge support for persons with schizophrenia in psychiatric hospitals?]. Ikebuchi E; Satoh S; Anzai N Seishin Shinkeigaku Zasshi; 2008; 110(11):1007-22. PubMed ID: 19202923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]